RxDoctor Payments Data

Jill McKenzie, MD

MOHS-Micrographic Surgery · Chandler, AZNPI 1154513661

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $461, 7.6 times the $61 reported in 2019. That places this record below the midpoint for mohs-micrographic surgery clinicians in AZ, where the typical reported total is $1,522.

$1,222in general payments, 2019–2025

Across 54 payments — averaging $22.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$213
  • Sanofi$206
  • Regeneron Healthcare Solutions, Inc.$201
  • Novartis$199
  • LEO Pharma Inc.$90
  • Incyte Corporation$82
  • plus $231 from 6 others

What the payments were for

  • Food & beverage$1,222100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,222 in reported general payments places this provider in the 35th percentile of 38 mohs-micrographic surgery providers in Arizona.

See all mohs-micrographic surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$598,265
Medicare patients
479
Services billed
1,419

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin195$1,450
Cephalexin48$171

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Chandler

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →